Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study - Dittmann, Ralf (CNS drugs, 2013)
Gesehen am: 10.03.2014